2025-07-11 - Analysis Report
Okay, let's analyze Honeywell International Inc. (HON) based on the provided data.

**Report on Honeywell International Inc. (HON)**

**1. Performance Overview & Comparison**

*   **Company Overview:** Honeywell International Inc. is a diversified technology and manufacturing company.

*   **Return Disparity:** HON's cumulative return is significantly lagging the S&P 500 (VOO).
    *   HON Cumulative Return: 50.81%
    *   VOO Cumulative Return: 96.17%
    *   Absolute Difference: -43.36%
    *   Relative Difference: 8.6 (This indicates HON's underperformance is in the lower range of its historical deviation from the S&P 500.)

*   **Alpha, Beta Analysis:**

    | Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
    |------------|---------|---------|---------|-------|--------|
    | 2015-2017  | 38.0%  | 56.2%  | 9.0%   | 0.1   | 94.5   |
    | 2016-2018  | 22.0%  | 63.2%  | 4.0%   | 0.1   | 85.0   |
    | 2017-2019  | 42.0%  | 63.2%  | 13.0%  | 0.5   | 113.9  |
    | 2018-2020  | 51.0%  | 63.2%  | 31.0%  | 0.3   | 136.8  |
    | 2019-2021  | 48.0%  | 59.4%  | 0.0%   | 0.2   | 134.1  |
    | 2020-2022  | 34.0%  | 70.8%  | 31.0%  | 0.2   | 137.8  |
    | 2021-2023  | -10.0% | 70.8%  | -28.0% | 0.6   | 134.9  |
    | 2022-2024  | -21.0% | 71.7%  | -47.0% | 0.6   | 145.3  |
    | 2023-2025  | -19.0% | 71.7%  | -67.0% | 1.1   | 152.3  |

    *   **Analysis:** The table shows HON's performance relative to the market (S&P 500) over rolling three-year periods.  Recent years show negative Alpha, meaning HON has underperformed the market on a risk-adjusted basis. The Beta values are generally low, indicating lower volatility than the market, but the recent increase in Beta suggests increasing sensitivity to market movements. CAGR 수치가 감소하고 MDD가 증가하는 추세가 나타난다.

**2. Recent Price Action**

*   **Current Price:** $236.77
*   **Previous Close:** $238.72
*   **Change:** -$0.82 (-0.82%)
*   **Moving Averages:**
    *   5-day MA: 238.66
    *   20-day MA: 229.81
    *   60-day MA: 219.96

*   **Analysis:** The price decreased slightly compared to the previous closing price. The price is below its 5-day moving average but above its 20-day and 60-day moving averages, suggesting a potential short-term downward trend but an overall upward trend in the medium term.

**3. Market Risk Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3373 (Low Risk)
*   **RSI:** 75.20 (Overbought)
*   **PPO:** 0.2889
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Delta_Previous_Relative_Divergence:** 2.1 (+), indicating a short-term upward trend.
*   **Expected Return:** -26.1% (suggests potential underperformance relative to the S&P 500 over a 2+ year investment horizon)

*   **Analysis:** The MRI indicates low market risk. The RSI is in overbought territory, potentially signaling a pullback. The positive delta of relative divergence also points to a short-term upward trend. The negative expected return is concerning. The Hybrid Signal suggests a cautious buy recommendation. The slight price decrease from the previous close doesn't suggest a major volatility event.

**4. Recent News & Significant Events**

*   **Recent News Highlights:**
    *   Major business developments, regulatory changes, or market events.
    *   Analyst discussions on performance in the context of industry and global economics.
    *   Stock volatility influenced by recent news, earnings, or executive actions.
    *   Market experts highlighting risks and opportunities.

*   **Analysis:** Recent news indicates a dynamic environment for HON, with potential volatility. Investors should monitor news and company announcements closely.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출     |
|------------|-------|----------|
| 2025-04-29 | 2.24  | 9.82 B$  |
| 2024-10-24 | 2.17  | 9.73 B$  |
| 2024-07-25 | 2.37  | 9.58 B$  |
| 2024-04-25 | 2.24  | 9.11 B$  |
| 2025-04-29 | 2.24  | 9.11 B$  |

*   **Analysis:** HON has shown consistent EPS. Recent revenue has been relatively stable.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $9.82B    | 38.54%        |
| 2024-12-31   | $10.09B   | 36.38%        |
| 2024-09-30   | $9.73B    | 38.54%        |
| 2024-06-30   | $9.58B    | 38.85%        |
| 2024-03-31   | $9.11B    | 38.68%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-03-31   | $17.46B   | 8.30%    |
| 2024-12-31   | $18.62B   | 6.90%    |
| 2024-09-30   | $17.41B   | 8.12%    |
| 2024-06-30   | $16.95B   | 9.11%    |
| 2024-03-31   | $16.45B   | 8.89%    |

*   **Analysis:** Revenue has been relatively consistent with slight growth. Profit margins are strong and stable. ROE has fluctuated but remains generally healthy.

**7. Overall Summary & Recommendation**

*   **Summary:** HON is a stable company with consistent revenue and healthy profitability. However, it has significantly underperformed the S&P 500 recently, with a negative expected return over a longer investment horizon.
*   **Recommendation:** Given the underperformance relative to the market, the high RSI (overbought), and the negative expected return, a cautious approach is warranted. Although the MRI indicates low risk, the hybrid signal suggests a cautious buy, which means that you should buy it carefully. Before investing, investors should conduct further due diligence, closely monitor news and company announcements, and consider the potential for a market pullback.
